MUCOSAL DRUG DELIVERY

WELCOME

OptimEyes' MNP (Mucoadhesive Nanoparticles) platform delivers small-molecule drugs directly to mucosal surfaces via a mucoadhesive polymer system that enables sustained, localized drug release. This approach improves bioavailability, compliance and safety, and supports topical delivery for multiple indications. The technology is applicable to all mucosal surfaces, across ophthalmology, respiratory, urogenital, women’s health, oncology and CNS pathologies.

OptimEyes’ MNP technology is a next generation drug delivery platform that maximizes the efficacy of new and existing APIs to improve patients lives

MNPs are enablers in all Mucosal Therapeutic Areas